Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population

References

• Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718–24.
   PubMed Web of Science ®Google Scholar
• Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjøsne U, Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108–15.
   PubMed Web of Science ®Google Scholar
• Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769–78.
   PubMed Web of Science ®Google Scholar
• Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399–408.
   PubMed Web of Science ®Google Scholar
• Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M, HFE mutations in patients with hereditary haemochromatosis in Sweden. J Internal Med 1998;243:203–8.
   Google Scholar
• McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC, A survey of 2851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619–24.
   PubMed Web of Science ®Google Scholar
• Fargion S, Mandelli C, Piperno A, Cesana B, Francanzani AL, Fraquelli M, Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655–9.
   PubMed Web of Science ®Google Scholar
• Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107–19.
   PubMed Web of Science ®Google Scholar
• Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368–72.
   PubMed Web of Science ®Google Scholar
• Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008;135:1945–52.
   PubMed Web of Science ®Google Scholar
• Milman N, Pedersen P, a Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 2001;80:737–44.
   PubMed Web of Science ®Google Scholar
• Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002;16:297–302.
   PubMed Web of Science ®Google Scholar
• Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003;125:1733–41.
   PubMed Web of Science ®Google Scholar
• Elmberg M, Hultcrantz R, Ebrahim F, Olsson S, Lindgren S, Lööf L, Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives. Gastroenterology 2009;137:1301–9.
   PubMed Web of Science ®Google Scholar
• Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish GR. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946–53.
   PubMedGoogle Scholar
• Brown AS, Gwinn M, Cogswell ME, Khoury MJ. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979–1997. Genet Med 2001;3:109–11.
   PubMedGoogle Scholar
• Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G–> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211–18.
   PubMed Web of Science ®Google Scholar
• McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. Gut 2006;55:554–62.
   PubMed Web of Science ®Google Scholar
• Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994;40:1631–6.
   PubMed Web of Science ®Google Scholar
• Stave GM, Mignogna JJ, Powell GS, Hunt CM. Evaluation of a workplace hemochromatosis screening program. Am J Prev Med 1999;16:303–6.
   PubMedGoogle Scholar
• Delatycki MB, Allen KJ, Nisselle AE, Collins V, Metcalfe S, du Sart D, Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 2005;366:314–16.
   PubMedGoogle Scholar
• Powell LW, Dixon JL, Ramm GA, Purdie DM, Lincoln DJ, Anderson GJ, Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006;166:294–301.
   PubMedGoogle Scholar
• Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962;84:53–64.
   PubMedGoogle Scholar
• Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929–36.
   PubMed Web of Science ®Google Scholar
• Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002;36:673–8.
   PubMed Web of Science ®Google Scholar
• Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;15: 138:627–33.
   Google Scholar
• Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 2004;103:2914–19.
   PubMed Web of Science ®Google Scholar
• Gleeson F, Ryan E, Barrett S, Crowe J. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur J Gastroenterol Hepatol 2004;16:859–63.
   PubMed Web of Science ®Google Scholar
• Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529–35.
   PubMed Web of Science ®Google Scholar
• Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162–66.
   PubMed Web of Science ®Google Scholar
• Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221–30.
   PubMed Web of Science ®Google Scholar
• Olsson KS, Ritter B, Rosen U, Heedman PA, Staugard F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213:145–50.
   PubMed Web of Science ®Google Scholar
• Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008;111:3373–6.
   PubMed Web of Science ®Google Scholar